Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Daito Pharmaceutical Co Ltd (4577)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2,502.0 +2.0    +0.08%
02:00:29 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3486150000 
  • Volume: 70,000
  • Bid/Ask: 2,502.0 / 2,508.0
  • Day's Range: 2,495.0 - 2,519.0
Daito Pharmaceutical 2,502.0 +2.0 +0.08%

4577 Balance Sheet

 
Featured here, the Balance Sheet for Daito Pharmaceutical Co Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2024
29/02
2023
30/11
2023
31/08
2023
31/05
Total Current Assets 42896 44853 41162 40663
Cash and Short Term Investments 3785 4585 4002 3607
Cash - - - -
Cash & Equivalents 3785 4585 4002 3607
Short Term Investments - - - -
Total Receivables, Net 16462 19016 17067 17654
Accounts Receivables - Trade, Net 16462 19016 17067 17654
Total Inventory 21315 19949 19019 18238
Prepaid Expenses - - - -
Other Current Assets, Total 1334 1303 1074 1164
Total Assets 77351 74990 71516 70552
Property/Plant/Equipment, Total - Net 30405 26029 26362 25837
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net 386 365 376 377
Long Term Investments 3662 3741 3615 3169
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 2 2 1 2
Other Assets, Total 6187 2236 3026 2252
Total Current Liabilities 18693 16411 16378 15428
Accounts Payable 9657 10182 9435 8172
Payable/Accrued - - - -
Accrued Expenses - - - 1091
Notes Payable/Short Term Debt - - - 69
Current Port. of LT Debt/Capital Leases 2110 2130 1379 1444
Other Current liabilities, Total 6926 4099 5564 4652
Total Liabilities 25307 22869 20185 19581
Total Long Term Debt 5194 5718 3043 3445
Long Term Debt 5194 5718 3043 3368
Capital Lease Obligations - - - 77
Deferred Income Tax - - - 31
Minority Interest 237 258 288 299
Other Liabilities, Total 1183 -7366 476 -4488
Total Equity 52044 52121 51331 50971
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total - 7186 7186 7186
Additional Paid-In Capital 7072 7072 7072 7072
Retained Earnings (Accumulated Deficit) 36131 36126 35257 35006
Treasury Stock - Common -121 -123 -124 -124
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 1776 1860 1940 1831
Total Liabilities & Shareholders' Equity 77351 74990 71516 70552
Total Common Shares Outstanding 15.7 15.8 15.8 15.8
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4577 Comments

Write your thoughts about Daito Pharmaceutical Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email